We’re thrilled to announce that we have closed a US$115 million Series B financing round to advance the development of bioprinted tissue therapeutics. Learn more:

Join Chief Scientific Officer Sam Wadsworth (@SamJWadsworth1) for a panel on "The Promise of Cell and Gene Therapies" at @lifesciences_bc's Access to Innovation conference. #LSBCaccess #CellTherapy #Biotech.

What do you want to know?.

Happy International Day of Women & Girls in Science! 🌟. Today, we celebrate women in STEM, at Aspect and around the globe, for their groundbreaking work in advancing scientific innovation! 🌎 👩‍🔬. #WomenInSTEM #WomenInScience #February11

Pleased to see our US$115 million Series B financing highlighted at the Toronto Stock Exchange #TSX. Thank you, @tsx_tsxv!

Thrilled to see the #Nasdaq tower in Times Square spotlighting our US$115 million Series B financing. Thank you, @Nasdaq @NasdaqExchange!

Exciting to see our US$115 million Series B financing featured on the #NYSE trading floor. Thank you, @NYSE!

Wishing everyone a wonderful holiday season, shared with friends and family. ❄️ 🌲 #HappyHolidays

On this #WorldDiabetesDay, we could not be more committed to our mission to develop bioprinted tissue therapeutics, alongside our partner @novonordisk, that could transform the lives of people living with diabetes.

@StemCellNetwork ➡️ Official sponsor of Wednesday’s breakfast session on “Women’s voices in regenerative medicine - journeys to leadership”. ➡️ Fireside chat with CEO Tamer Mohamed (@_tamerm) at industry symposium on commercializing regenerative medicine in Canada.#TMM2024 #StemCells #RegenMed.

#TMM2024, hosted by @StemCellNetwork, has kicked off in Montreal this week and we are proud to be sponsoring and participating!. Connect with us at the following events:.➡️ Booth at Career Connect - stop by to learn about our team and opportunities to join us!

Join CEO Tamer Mohamed (@_tamerm) for a fireside chat during the industry symposium on "Innovate to Elevate: Commercializing Regenerative Medicine in Canada" at @StemCellNetwork's #TMM2024. 📅 November 6, 1:50pm ET.📍 Montréal, QC. Learn more:

We are proud to share that CEO Tamer Mohamed (@_tamerm) has joined @BIOTECanada's Board of Directors. Read the full press release:

CEO Tamer Mohamed (@_tamerm) sharing updates on our development of bioprinted tissue therapeutics for metabolic and endocrine diseases at @alliancerm's #CGMesa24

CEO Tamer Mohamed (@_tamerm) will present at @allliancerm's Cell & Gene Meeting on the Mesa. #CGMesa24. 📅 October 7, 2:15pm MST.📍 Phoenix, AZ. Learn more:

Join CEO Tamer Mohamed (@_tamerm) for a panel on "Embracing & Accelerating Biotech Innovation" at @BIOTECanada's #BIONATION2024. 📅 Tuesday September 24, 2:40pm EDT.📍 Ottawa, ON. Learn more: #GBW2024 #biotech #CdnInnovation

Aspect has been awarded @BIOTECanada's 2024 Gold Leaf Award for Biotech Company of the Year! 🎉. This award "celebrates a distinguished organization that has made significant contributions to the Canadian biotechnology sector.". Learn more:

Wishing everyone in British Columbia a happy #BCDay! We are proud to call this beautiful province home. ⛰️

@FP_Champagne @BrendaBaileyBC @NdpJoan Our $200 million partnership with the governments of Canada and British Columbia will advance our unique clinical biomanufacturing capabilities, full-stack tissue therapeutic platform, and pipeline of bioprinted tissue therapeutics. Press release:

A snapshot of the partnership announcement we recently hosted with the Government of Canada and Government of BC. Thanks to Minister @FP_Champagne, Minister @BrendaBaileyBC, MLA @NdpJoan, and guests from across our life sciences ecosystem for joining us on that exciting day!

RT @bcbusiness: Vancouver-based @aspectbiosys is working to help incurable diseases like Type 1 diabetes. Earlier this week, government min….